Frédéric Di Fiore

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +14

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui et al. · Clinical Cancer Research · 2017 · 251 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer

Frédéric Di Fiore, Stéphane Lecleire, Daniela Pop et al. · The American Journal of Gastroenterology · 2007 · 183 citations

Medicine, Nutrition, Oncology +17

Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations

David Tougeron, Émilie Fauquembergue, Alexandre Rouquette et al. · Modern Pathology · 2009 · 151 citations

Medicine, Genetics, Oncology +14

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 96 citations

Medicine, Oncology, Pharmacology +14